Why it was recalled
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Product description
SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01
Lot numbers, UPCs & expiration codes
Lot: AC-017273, Exp. 12/12/2026.
Where it was sold
Nationwide within the U.S
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0755-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Jul 29, 2026
- FDA report date
- Aug 19, 2026
- Quantity
- 250 vials.
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Apollo Care, LLC
Original FDA data
Every field from FDA enforcement report D-0755-2026, exactly as published.
Show all FDA fields
- City
- Columbia
- State
- MO
- Status
- Ongoing
- Country
- United States
- Event ID
- 99505
- Address
- 3801 Mojave Ct Ste 101
- Code information
- Lot: AC-017273, Exp. 12/12/2026.
- Postal code
- 65202-4042
- Report date
- Aug 19, 2026
- Product type
- Drugs
- Recall number
- D-0755-2026
- Classification
- Class II
- Recalling firm
- Apollo Care, LLC
- Product quantity
- 250 vials.
- Reason for recall
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01
- Distribution pattern
- Nationwide within the U.S
- Recall initiation date
- Jul 29, 2026
- Initial firm notification
- Center classification date
- Aug 7, 2026